205 related articles for article (PubMed ID: 10494035)
1. The haemostatic balance -- Astrup revisited.
Gaffney PJ; Edgell TA; Whitton CM
Haemostasis; 1999 Sep; 29(1):58-71. PubMed ID: 10494035
[TBL] [Abstract][Full Text] [Related]
2. Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction.
Toh CH
Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S69-71. PubMed ID: 14567541
[TBL] [Abstract][Full Text] [Related]
3. Myocardial infarction and the balance between fibrin deposition and removal.
Nesheim M
Ital Heart J; 2001 Sep; 2(9):641-5. PubMed ID: 11666089
[TBL] [Abstract][Full Text] [Related]
4. The coagulation system in humans.
Chan AK; Paredes N
Methods Mol Biol; 2013; 992():3-12. PubMed ID: 23546701
[TBL] [Abstract][Full Text] [Related]
5. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
Bouma BN; Mosnier LO
Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
[TBL] [Abstract][Full Text] [Related]
6. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
Stasko J; Hudecek J; Kubisz P
Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation.
Norris LA
Best Pract Res Clin Obstet Gynaecol; 2003 Jun; 17(3):369-83. PubMed ID: 12787532
[TBL] [Abstract][Full Text] [Related]
8. Normal haemostasis and its regulation.
Mackie IJ; Bull HA
Blood Rev; 1989 Dec; 3(4):237-50. PubMed ID: 2692745
[TBL] [Abstract][Full Text] [Related]
9. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.
Bouma BN; Mosnier LO
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):375-81. PubMed ID: 15692247
[TBL] [Abstract][Full Text] [Related]
10. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
[TBL] [Abstract][Full Text] [Related]
11. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
[TBL] [Abstract][Full Text] [Related]
12. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
13. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
Nesheim M; Wang W; Boffa M; Nagashima M; Morser J; Bajzar L
Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184
[TBL] [Abstract][Full Text] [Related]
14. [The TAFI system. The new role of fibrinolysis].
Dempfle CE
Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
[TBL] [Abstract][Full Text] [Related]
15. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
16. Role of Factor XII in hemostasis and thrombosis: clinical implications.
Renné T; Gailani D
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
[TBL] [Abstract][Full Text] [Related]
17. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
Mosnier LO; Bouma BN
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2445-53. PubMed ID: 16960106
[TBL] [Abstract][Full Text] [Related]
18. Plasma and cellular contributions to fibrin network formation, structure and stability.
Wolberg AS
Haemophilia; 2010 May; 16 Suppl 3():7-12. PubMed ID: 20586795
[TBL] [Abstract][Full Text] [Related]
19. [Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?].
Drouet L; Bal dit Sollier C
Therapie; 2005; 60(2):137-47. PubMed ID: 15969316
[TBL] [Abstract][Full Text] [Related]
20. Thrombin and fibrinolysis.
Nesheim M
Chest; 2003 Sep; 124(3 Suppl):33S-9S. PubMed ID: 12970122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
